Top Markets
#1 Useless Coin Useless Coin +39.03%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.96%
#3 0G 0G +36.39%
#4 StonkBroker StonkBroker +35.78%
#5 SAFEcoin SAFEcoin +29.23%
#6 Arbitrum Arbitrum +22.61%
#7 Zora Zora +20.61%
#8 Full Moon Full Moon +18.06%
#9 Notcoin Notcoin +18.04%
#10 Dogs Dogs +17.45%
Coin of the day
Useless Coin Useless Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
Clasificación en acciones #13820
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Precio por acción
$12.63
Capitalización bursátil
$458.19M
Cambio (1 día)
-3.26%
Cambio (1 año)
-
País
US
Comercio Evommune, Inc. (EVMN)

Categoría

Healthcare
Historial del precio de la acción de Evommune, Inc. (EVMN)
Precio más alto de cierre: $13.94 el 2026-08-01

Precio más bajo de cierre: $19.25 el 2025-11-01
Historial del precio de la acción de Evommune, Inc. desde 2025 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 9.44%
2025 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.87%
CH